GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021)
GeneDx Holdings (WGS) posted quarterly Long-Term Investments of $442.8 million for Q2 2021, little changed quarter-over-quarter from $442.8 million in Q1 2021.
GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Long-Term Investments for 2 consecutive years, with $442.8 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Long-Term Investments changed N/A year-over-year to $442.8 million; the TTM figure through Jun 2021 stood at $442.8 million (changed N/A YoY), while the FY2020 annual figure was $442.8 million, changed N/A from the prior year.
- Long-Term Investments steadied at $442.8 million in Q2 2021 per WGS's latest filing, from $442.8 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $442.8 million in Q2 2021 and bottomed at $442.8 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 136.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 390.00 Mn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 137.00 Mn |
| 10 | GeneDx Holdings | 2.08 Bn | 1.95 Bn | 78.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 442.79 Mn |
| Mar 31, 2021 | 442.77 Mn |
| Dec 31, 2020 | 442.76 Mn |
| Sep 30, 2020 | 442.75 Mn |